Richter Life Science is excited to provide the Optotracing™ sensing technology, a disruptive solution beyond the state-of-the-art.
We are committed to translate the cutting-edge research that advances our knowledge base into societal use. By engaging scientists with an entrepreneurial mindset, we bring science to society. Our vision is to offer disruptive, pan-industrial technologies applicable in several marketplaces, thereby aiding in realizing the United Nations Sustainable Development Goals for a healthy planet.Contact us
Healthcare and modern industries depend on analytical devices to thrive in the rapidly evolving data-driven digital environment. Process industry controls and optimizes manufacturing processes with various sensors, and health-care uses biosensors for clinical analysis and diagnostics.
Sensors tailored to emerging industries such as the merger of IT and health care, as well as the growing bio-based industry driving towards a fossil-free bio-economy, are however scarce.
Established and new industries alike have a common need to harness the power of sensor technologies not currently available. This is what Richter Life Science Development wants to change.
Pharma Quality Control
Antibiotics Biofilm Targeted Delivery
AI Analytics Big Data
Pulp & Paper
Art & Design
Optotracing™ is a new, direct sensing technology based on opto-electronicallly active molecules. Binding of the optotracer to a target acts as a light switch – the optotracer starts to emit a signal by which we can identify the target. What used to be black and white can now be seen in a wide range of colors.
The subsidiary Ebba Biotech AB offers the Optotracing™ technology to the global academic and industrial biotech research community. The world’s most prestigious universities such as Stanford, Oxford, and Cambridge have adopted the method and verified its performance.